Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
28.97
+0.88 (3.13%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $850.26 million as of July 26, 2024. Its market cap has increased by 1,705.21% in one year.
Market Cap
850.26M
Enterprise Value
473.72M
1-Year Change
1,705.21%
Ranking
Category
Stock Price
$28.97
Market Cap Chart
Since June 21, 2018, Dianthus Therapeutics's market cap has increased from $499.10M to $850.26M, an increase of 70.36%. That is a compound annual growth rate of 9.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 824.40M | 434.98% |
Dec 29, 2023 | 154.10M | 544.77% |
Dec 30, 2022 | 23.90M | -90.82% |
Dec 31, 2021 | 260.40M | -31.24% |
Dec 31, 2020 | 378.70M | -35.93% |
Dec 31, 2019 | 591.10M | 212.75% |
Dec 31, 2018 | 189.00M | -62.13% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Harrow Health | 859.07M |
Standard BioTools | 848.26M |
Olema Pharmaceuticals | 835.09M |
Cytek Biosciences | 827.02M |
CureVac | 823.23M |
InnovAge Holding | 811.85M |
OrthoPediatrics | 809.94M |
Atrion | 805.81M |